Skip to search formSkip to main contentSkip to account menu

exametazime

Known as: 3,3'-((2,2,-dimethyl-1,3-propanediyl)diimino)bis-2-butanone dioxime, (R*,R*-(E,E))- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Butanones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Brain Perfusion Scintigraphy in Evaluation of Pathogenesis of Fatigue in Patients with Primary Biliary Cholangitis (PBC) – A Pilot Study
Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease characterized by a breakdown of immune tolerance to… 
2004
2004
99 mTc-Exametazime as a Breast Tumor – Seeking Agent : Comparison with 99 mTc-Sestamibi
99mTc-Sestamibi is commonly used for mammoscintigraphy. Occasional uptake of 99mTc-exametazime in various tumors has been… 
1999
1999
Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits.
: Fractionation of 99Tcm-exametazime enables several patients doses to be prepared from one vial. To overcome the disadvantages… 
1997
1997
PP-19: Scintigraphic studies with exametazime-labelled granulocytes are expensive
1997
1997
26. A novel approach to multidose tin-enhanced exametazime for leukocyte labelling
1994
1994
ICTAL INJECTION OF TC-99M-STABILIZED-EXAMETAZIME: INITIAL EXPERIENCE AND CLINICAL CORRELATION
1993
1993
99. Stabilization and multidose usage of exametazime: the saga continues
1992
1992
EXAMETAZIME UPTAKE AFTER ECT: A SPET STUDY
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)